Table 3.
Effect | OR Any AEs |
95% CI Any AEs |
OR Any SAEs |
95% CI Any SAEs |
---|---|---|---|---|
Age | ||||
0–3 mo | 1.01 | 0.68–1.52 | 1.23 | 0.51–2.92 |
4–12 mo | 0.79 | 0.63–0.99 | 1.05 | 0.65–1.70 |
1–13 yr | 0.86 | 0.75–1.00 | 0.34 | 0.8–1.84 |
> 13 yr | Reference | Reference | ||
American Society of Anesthesiologists- Physical Status |
||||
≥ III | 1.11 | 0.98–1.25 | 1.26 | 0.99–1.62 |
< III | Reference | Reference | ||
Location | ||||
Cardiac catheterization laboratory | 1.19 | 0.49–2.89 | 1.61 | 0.36–7.14 |
Dental suite | 3.75 | 1.74–8.06 | 1.39 | 0.18–10.48 |
Emergency department | 0.71 | 0.57–0.88 | 0.42 | 0.21–0.84 |
Other | 0.99 | 0.81–1.21 | 0.72 | 0.46–1.13 |
PICU | 0.82 | 0.66–1.03 | 0.85 | 0.54–1.33 |
Specialty floor/clinic | 1.13 | 0.91–1.41 | 0.64 | 0.37–1.12 |
Radiology/sedation | Reference | Reference | ||
Painful procedure: yes | 0.88 | 0.78–0.99 | 0.78 | 0.62–0.97 |
Adjunctive medication | ||||
Benzodiazepine | 0.61 | 0.54–0.68 | 0.42 | 0.33–0.53 |
Anticholinergic | 1.67 | 1.48–1.89 | 2.92 | 2.35–3.63 |
Propofol | 1.79 | 1.59–2.02 | 5.36 | 4.08–7.05 |
Barbiturate | 3.34 | 1.83–6.12 | 2.03 | 0.48–8.58 |
Primary diagnosis | ||||
Cardiology | 2.38 | 1.64–3.46 | 1.41 | 0.60–3.31 |
Hematology/oncology | 0.57 | 0.49–0.67 | 0.63 | 0.46–0.85 |
Gastrointestinal | 1.40 | 1.18–1.65 | 1.10 | 0.79–1.53 |
Lower respiratory illness | 1.67 | 1.23–2.27 | 1.53 | 0.86–2.71 |
AEs = adverse events, OR = odds ratio, SAEs = serious adverse events.
Boldface values denote statistical significance, p < 0.05.